Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus-Reference-Cited by-同舟云学术

Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus

Published:2010-03-09 Issue:5 Volume:11 Page:689-699
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Djabarouti Sarah,Duffau Pierre,Lazaro Estibaliz,Chapouly Candice,Greib Carine,Viallard Jean-François,Pellegrin Jean-Luc,Saux Marie-Claude,Breilh Dominique

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656561003592144

Reference30 articles.

1. Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study

2. Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years

3. Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant Recipients

4. Review of the immunosuppressant enteric-coated mycophenolate sodium

5. Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The fluorescence and colorimetric dual-readout probe for clinical rapid detection of mycophenolic acid by the poly(ethylenimine)/silica-coated CdTe quantum dots;Analytical Biochemistry;2023-05

2. Intérêt des dosages pharmacologiques d’immunosuppresseurs et immunomodulateurs dans la prise en charge des maladies autoimmunes;La Revue de Médecine Interne;2022-07

3. Precision Medicine;Rheumatic Disease Clinics of North America;2022-02

4. The use of mycophenolate mofetil area under the curve;Current Opinion in Rheumatology;2021-03-17

5. Deeskalation und glukokortikoidfreie Therapie bei SLE;Zeitschrift für Rheumatologie;2021-03-15